# Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

> **NCT02363218** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 117 (estimated)

## Conditions studied

- Liver Neoplasms

## Interventions

- **RADIATION:** CyberKnife

## Key facts

- **NCT ID:** NCT02363218
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2016-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02363218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02363218, "Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02363218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*